Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  138 results for ""Sodium-Glucose Transporter 2 Inhibitors""

Your Filters

Publisher : wiley Subject : biomarkers Subject : diabetes mellitus, type 2 Subject : glucose intolerance Subject : heart failure Subject : hypertension
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

Association of sodium-glucose cotransporter 2 inhibitors with changes in comprehensive geriatric assessment in elderly diabetic patients with heart failure: Data from MAGIC-HF.

  • Authors : Armentaro G; Department of Medical and Surgical Sciences, 'Magna Græcia' University, Catanzaro, Italy.; Cassano V

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: European journal of heart failure [Eur J Heart Fail] 2024 Apr; Vol. 26 (4), pp. 1095-1097. Date of Electronic Publication: 2024 Apr 28.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

SGLT2 Inhibitors' Cardiovascular Benefits in Individuals Without Diabetes, Heart Failure, and/or Chronic Kidney Disease: A Systematic Review.

  • Authors : Khiali S; Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.; Taban-Sadeghi M

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/drug therapy

  • Source: Journal of clinical pharmacology [J Clin Pharmacol] 2023 Dec; Vol. 63 (12), pp. 1307-1323. Date of Electronic Publication: 2023 Aug 02.Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Sodium-glucose cotransporter-2 inhibitors in heart failure: Potential decongestive mechanisms and current clinical studies.

  • Authors : Biegus J; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.; Fudim M

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/pharmacology ; Heart Failure*

  • Source: European journal of heart failure [Eur J Heart Fail] 2023 Sep; Vol. 25 (9), pp. 1526-1536. Date of Electronic Publication: 2023 Jul 26.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Similarities and distinctions between acetazolamide and sodium-glucose cotransporter 2 inhibitors in patients with acute heart failure: Key insights into ADVOR and EMPULSE.

  • Authors : Packer M; Baylor University Medical Center, Dallas, TX, USA.; Imperial College, London, UK.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/pharmacology ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy

  • Source: European journal of heart failure [Eur J Heart Fail] 2023 Sep; Vol. 25 (9), pp. 1537-1543. Date of Electronic Publication: 2023 Jul 17.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Sodium-glucose cotransporter 2 inhibitors in hospitalized heart failure patients: No time like now.

  • Authors : Kalra R; Cardiovascular Division, University of Minnesota, Minneapolis, MN, USA.; Center for Resuscitation Medicine, University of Minnesota, Minneapolis, MN, USA.

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Diabetes Mellitus, Type 2*

  • Source: European journal of heart failure [Eur J Heart Fail] 2023 Oct; Vol. 25 (10), pp. 1806-1807. Date of Electronic Publication: 2023 Sep 10.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

The frail patient and the frailing heart. Letter regarding the article 'Barcelona Bio-HF calculator version 3.0: recalibration and incorporation of sodium-glucose cotransporter 2 inhibitor treatment'.

  • Authors : Patoulias D; Second Department of Cardiology, Aristotle University of Thessaloniki, General Hospital 'Hippokration', Thessaloniki, Greece.; Fragakis N

Subjects: Diabetes Mellitus, Type 2* ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

  • Source: European journal of heart failure [Eur J Heart Fail] 2023 Mar; Vol. 25 (3), pp. 441. Date of Electronic Publication: 2023 Feb 02.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Effects of empagliflozin on erythropoiesis in heart failure: data from the Empire HF trial.

  • Authors : Fuchs Andersen C; Department of Cardiology, Herlev and Gentofte University Hospital, Herlev, Denmark.; Omar M

Subjects: Heart Failure* ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

  • Source: European journal of heart failure [Eur J Heart Fail] 2023 Feb; Vol. 25 (2), pp. 226-234. Date of Electronic Publication: Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Barcelona Bio-HF calculator version 3.0: recalibration and incorporation of sodium-glucose cotransporter 2 inhibitor treatment.

  • Authors : Codina P; Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/metabolism ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: European journal of heart failure [Eur J Heart Fail] 2023 Jan; Vol. 25 (1), pp. 131-132. Date of Electronic Publication: 2022 Dec 20.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Reduced.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Heart Failure*/Heart Failure*/Heart Failure*/complications

  • Source: European journal of heart failure [Eur J Heart Fail] 2022 Oct; Vol. 24 (10), pp. 1829-1839. Date of Electronic Publication: 2022 Jul 07.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Early changes in renal function after sodium-glucose cotransporter 2 inhibitor initiation in EMPEROR-Reduced: the end of the dilemma?

  • Authors : Beldhuis IE; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands.; Martens P

Subjects: Heart Failure* ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: European journal of heart failure [Eur J Heart Fail] 2022 Oct; Vol. 24 (10), pp. 1840-1843. Date of Electronic Publication: 2022 Sep 05.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  138 results for ""Sodium-Glucose Transporter 2 Inhibitors""